130 related articles for article (PubMed ID: 36609594)
21. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
22. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
Chen J; Li S; Shen Q; He H; Zhang Y
Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
[TBL] [Abstract][Full Text] [Related]
23. Idarubicin-loaded methoxy poly(ethylene glycol)-
Liang B; Li N; Zhang S; Qi A; Feng J; Jing W; Shi C; Ma Z; Gao S
Int J Nanomedicine; 2019; 14():543-556. PubMed ID: 30666113
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
[TBL] [Abstract][Full Text] [Related]
25. Rhoifolin loaded in PLGA nanoparticles alleviates oxidative stress and inflammation
Al-Shalabi E; Abusulieh S; Hammad AM; Sunoqrot S
Biomater Sci; 2022 Sep; 10(19):5504-5519. PubMed ID: 35920694
[TBL] [Abstract][Full Text] [Related]
26. Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides.
Nunes R; Araújo F; Barreiros L; Bártolo I; Segundo MA; Taveira N; Sarmento B; das Neves J
ACS Appl Mater Interfaces; 2018 Oct; 10(41):34942-34953. PubMed ID: 30234288
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
[TBL] [Abstract][Full Text] [Related]
28. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
[TBL] [Abstract][Full Text] [Related]
29. Low molecular weight PEG-PLGA polymers provide a superior matrix for conjugated polymer nanoparticles in terms of physicochemical properties, biocompatibility and optical/photoacoustic performance.
Abelha TF; Neumann PR; Holthof J; Dreiss CA; Alexander C; Green M; Dailey LA
J Mater Chem B; 2019 Sep; 7(33):5115-5124. PubMed ID: 31363720
[TBL] [Abstract][Full Text] [Related]
30. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
Kavas A; Keskin D; Altunbaş K; Tezcaner A
Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
[TBL] [Abstract][Full Text] [Related]
31. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
32. Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery.
Kaldybekov DB; Filippov SK; Radulescu A; Khutoryanskiy VV
Eur J Pharm Biopharm; 2019 Oct; 143():24-34. PubMed ID: 31419584
[TBL] [Abstract][Full Text] [Related]
33. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
[TBL] [Abstract][Full Text] [Related]
34. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
[TBL] [Abstract][Full Text] [Related]
35. Polyethylene Glycol-Poly-Lactide-co-Glycolide Block Copolymer-Based Nanoparticles as a Potential Tool for Off-Label Use of N-Acetylcysteine in the Treatment of Diastrophic Dysplasia.
Chiesa E; Monti L; Paganini C; Dorati R; Conti B; Modena T; Rossi A; Genta I
J Pharm Sci; 2017 Dec; 106(12):3631-3641. PubMed ID: 28826881
[TBL] [Abstract][Full Text] [Related]
36. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
37. Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform.
Bao Y; Maeki M; Ishida A; Tani H; Tokeshi M
PLoS One; 2022; 17(8):e0271050. PubMed ID: 35925917
[TBL] [Abstract][Full Text] [Related]
38. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.
Katsikogianni G; Avgoustakis K
J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521
[TBL] [Abstract][Full Text] [Related]
39. Small-Sized mPEG-PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity.
Chen T; Li C; Li Y; Yi X; Wang R; Lee SM; Zheng Y
ACS Appl Mater Interfaces; 2017 Mar; 9(11):9516-9527. PubMed ID: 28247754
[TBL] [Abstract][Full Text] [Related]
40. Release of adriamycin from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles.
Mo SM; Oh IJ
J Nanosci Nanotechnol; 2011 Feb; 11(2):1795-8. PubMed ID: 21456294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]